Epilepsy occurrence in patients with Alzheimer’s disease: clinical experience in a tertiary dementia center
Letter to the Editor
First Online:
Received:
Accepted:
- 345 Downloads
- 4 Citations
Keywords
Alzheimer’s disease Epilepsy Seizures Database EEG Antiepileptic drugsNotes
Compliance with ethical standards
Conflict of interest
In the past year, Ubaldo Bonuccelli has received fees for consultation from GSK and Eisai and for speeches from Novartis, GSK and Lundbeck. The remaining authors have nothing to declare.
References
- 1.Palop JJ, Mucke L (2009) Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 66(4):435–440CrossRefPubMedPubMedCentralGoogle Scholar
- 2.Friedman D, Honig LS, Scarmeas N (2012) Seizures and epilepsy in Alzheimer disease. CNS Neurosci Ther 18:285–294CrossRefPubMedPubMedCentralGoogle Scholar
- 3.McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS–ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34(7):939–944CrossRefPubMedGoogle Scholar
- 4.Hauser WA, Annegers JF, Kurland LT (1993) Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia 34(3):453–468CrossRefPubMedGoogle Scholar
- 5.Vossel KA, Beagle AJ, Rabinovici GD et al (2013) Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol 70(9):1158–1166CrossRefPubMedPubMedCentralGoogle Scholar
Copyright information
© Springer-Verlag Italia 2015